Chau T. Dang, MD, Discusses the APHINITY Trial
December 26, 2019

The breast cancer expert spoke about the results presented in the trial, noting the benefit seen with longer follow-up.

Madelaine Kuiper, MSN, NP, Discusses Rapid Development of HER2-Targeted Therapies
December 24, 2019

The nurse practitioner from UCLA Health spoke about the expanding treatment options in this setting.

Erica L. Mayer, MD, MPH, Discusses New Targeted Therapies in Breast Cancer Treatment
December 23, 2019

The expert explained her research focused on the role of CDK4/6 inhibitors in treating breast cancer.